meglumine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Herold, CJ; Knosp, E; Kramer, J; Math, G; Mostbeck, G; Steiner, E | 1 |
Ikeda, H; Kobayashi, S; Yoshimoto, T | 1 |
Bishop, JE; George, S; Keller, MA; Kucharczyk, W; Plewes, DB | 1 |
Bakke, SJ; Hald, JK; Nakstad, PH; Skalpe, IO | 1 |
2 trial(s) available for meglumine and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging.
Topics: Adenoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1994 |
MR imaging of pituitary region lesions with gadodiamide injection.
Topics: Adenoma; Adult; Aged; Contrast Media; Craniopharyngioma; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Diseases; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1994 |
2 other study(ies) available for meglumine and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
Topics: Adenoma; Adult; Aged; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Postoperative Care; Preoperative Care; Prolactinoma; Retrospective Studies | 1994 |
A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Cell Count; Contrast Media; Drug Combinations; Female; Follicle Stimulating Hormone; Gadolinium DTPA; Growth Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Paraneoplastic Endocrine Syndromes; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin | 1994 |